Amneal Pharmaceuticals, Inc.
AMRX· Nasdaq
AMRXAmneal Pharmaceuticals, Inc.
Filed Aug 5, 2019 · 10-Q · 36 days after period end · 0001723128-19-000111
| Metric | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|
| Revenue | $404.64M | $413.79M | $259.87M |
| Net Income | -$16.90M | -$17.86M | $0.00 |
| EPS Diluted | -$0.13 | -$0.15 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amneal Pharmaceuticals, Inc. · CIK 1723128 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 5, 2019 · 36 d after period end
